Nuclear Medicine Study Of Heart Muscle With Metabolic And Blood Flow Evaluation Requiring 2 Injections And Concurrent Ct Scan in California
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in California
| Provider | Medicare | Services |
|---|---|---|
| Hayes, Sean MD | $85.54 | 22 |
California Pricing in Context
In California, CPT code 78433 (Nuclear Medicine Study Of Heart Muscle With Metabolic And Blood Flow Evaluation Requiring 2 Injections And Concurrent Ct Scan) carries an average Medicare payment of $655.34 — 146% above the national benchmark of $266.28. 19 providers across the state submitted claims for this procedure in 2023, performing 64 total services. Individual payments in CA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in California is $4,209.22, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because California sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for CT Scan procedures, the estimated commercial insurance price in California lands near $2,013.26, with self-pay cash prices typically around $1,786.68. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Nuclear Medicine Study Of Heart Muscle With Metabolic And Blood Flow Evaluation Requiring 2 Injections And Concurrent Ct Scan cost in California?
The average Medicare payment for Nuclear Medicine Study Of Heart Muscle With Metabolic And Blood Flow Evaluation Requiring 2 Injections And Concurrent Ct Scan in California is $655.34, which is 146% above the national average of $266.28. Providers in CA typically bill $4,209.22 for this procedure.
What does Nuclear Medicine Study Of Heart Muscle With Metabolic And Blood Flow Evaluation Requiring 2 Injections And Concurrent Ct Scan cost with insurance in California?
With commercial insurance in California, Nuclear Medicine Study Of Heart Muscle With Metabolic And Blood Flow Evaluation Requiring 2 Injections And Concurrent Ct Scan costs an estimated $2,013.26. Without insurance, the estimated cash price is $1,786.68. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Nuclear Medicine Study Of Heart Muscle With Metabolic And Blood Flow Evaluation Requiring 2 Injections And Concurrent Ct Scan in California?
19 providers in California billed Medicare for Nuclear Medicine Study Of Heart Muscle With Metabolic And Blood Flow Evaluation Requiring 2 Injections And Concurrent Ct Scan in 2023, performing 64 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Nuclear Medicine Study Of Heart Muscle With Metabolic And Blood Flow Evaluation Requiring 2 Injections And Concurrent Ct Scan cheaper in California than the national average?
No — Nuclear Medicine Study Of Heart Muscle With Metabolic And Blood Flow Evaluation Requiring 2 Injections And Concurrent Ct Scan costs 146% above the national average in California. The state average Medicare payment is $655.34 compared to $266.28 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.